Apple Inc.

**Signal Note: Driehaus Growth Initiates Apple Position** This move is notable given Driehaus's biotech-focused mandate—the $2.7M Apple position suggests conviction in tech exposure as a portfolio hedge or reflects conviction in Apple's healthcare/wearables strategy (continuous glucose monitoring, health sensors). However, without visibility into the fund's overall positioning changes or cash flows, the significance remains limited; a single $2.7M position in a growth-oriented fund could represent either strategic allocation or opportunistic buying during market dislocation.